secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mineralys Therapeutics, Inc. (MLYS)
CIK:        0001933414
Form:       8-K
Filed at:   2025-05-22T23:59:59+00:00
Accession:  0001933414-25-000064
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders elect two Class II directors; ratify EY as auditor for FY2025
--------------------------------------------------------------------------

- Glenn P. Sblendorio elected with 45.4M for (85.8% of votes cast) and Derek DiRocco with 45.3M for (85.6%).
- Ernst & Young ratified as independent auditor for FY2025: 59.1M for, 5.9K against, 191K abstentions.
- Over 6.3M broker non-votes on director elections; none on auditor ratification.
- Annual meeting held May 22, 2025; all proposals passed with requisite majority.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1933414/000193341425000064/0001933414-25-000064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1933414/000193341425000064/mlys-20250522.htm
  HTML page:      https://secwatch.observer/filing/0001933414-25-000064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer